Quantum Pharma launches Mucodis Rectal Gel
Quantum Pharma said Colonis has launched its Mucodis Rectal Gel for preventing and treating rectal mucositis, a common side effect of chemotherapy and radiotherapy in cancer patients.
Pharmaceuticals & Biotechnology
19,794.96
16:38 14/11/24
0.96%
187.95
Quantum Pharma
84.25p
16:09 30/10/17
0.00%
0.00p
Mucositis is a condition characterised by pain and inflammation of the body's mucous membranes which line the digestive system from the mouth to the anus.
Colonis is part of AIM-quoted Quantum's Niche Pharmaceuticals division.